Shinpoong Pharmaceutical Co., Ltd.: Business Overview, Financials & Competitive Analysis
Shinpoong Pharmaceutical Co., Ltd. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Established Korean generics player with improving profitability but facing market share pressures against larger regional competitors. Revenue grew 10.4% year-over-year in 2024 to $162.2M with strong net income growth of 73.2%, demonstrating operational improvement. However, the company underperformed both its industry and the broader market over the past.
What is Shinpoong Pharmaceutical Co., Ltd.'s industry? Shinpoong Pharmaceutical Co., Ltd. (shinpoong.co.kr) operates in Pharmaceuticals and Healthcare. AskCyborg classifies Shinpoong Pharmaceutical Co., Ltd. under Pharmaceuticals and Healthcare in its company registry.
Shinpoong Pharmaceutical manufactures and sells pharmaceutical products in South Korea, offering cephalosporin antibiotics, penicillin antibiotics, antivirals, anticancer drugs, painkillers, anti-inflammatory products...
Cyborg Score thesis
Established Korean generics player with improving profitability but facing market share pressures against larger regional...
Read the full analyst-debate transcript →Get the Latest Shinpoong Pharmaceutical Co., Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeShinpoong Pharmaceutical Co., Ltd. Overview
Pro stress-test →Shinpoong Pharmaceutical manufactures and sells pharmaceutical products in South Korea, offering cephalosporin antibiotics, penicillin antibiotics, antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. The company exports its products to approximately 50 countries.
Strategic Profile
Pro stress-test →The company provides active pharmaceutical ingredients, Pyramax (an anti-malarial drug), and drugs for treating hypercholesterolemia, knee osteoarthritis, shoulder periarthritis, and surgical adhesion barriers, plus prescription drugs, wound dressings, health functional food, and over-the-counter products. The company maintains a diversified portfolio spanning generic antibiotics to specialized therapeutics, positioning itself as a vertically-integrated domestic Korean pharmaceutical player.
Competitive Landscape
Pro stress-test →Shinpoong competes within the South Korean pharmaceutical market alongside established players like Samsung Pharm, Yuhan Corp, Boryung Corp, and GC Biopharma. As a mid-sized domestic player with ~840 employees, the company focuses on generic and specialty pharmaceuticals rather than biotech innovation, positioning it against larger multinational generics manufacturers and regional healthcare conglomerates.
Industry Context
Shinpoong Pharmaceutical Co., Ltd. operates in Pharmaceuticals and Healthcare.
Key facts
Founded: 1962 · Headquarters: Seoul, South Korea · Employees: 840 · Revenue: $162.2M · Market cap: $503.6M